Satoh, M. (2011) “Clinical Assessment of Bortezomib for Multiple Myeloma in Comparison with Thalidomide”, Journal of Pharmacy & Pharmaceutical Sciences, 14(1), pp. 78–89. doi: 10.18433/J3VP44.